Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Company Overview
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
| Name: | Regeneron Pharmaceuticals Inc. |
|---|---|
| Address: | 777 Old Saw Mill River Road Tarrytown, New York 10591 |
| Phone: | (914) 847-7000 |
| Email: | michael.aberman@regeneron.com |
| Web site: | www.regeneron.com |
| CEO: | NA |
| % Owned By | Shares Bought In Last 90 Days | Shares Sold In Last 90 Days | |
| Insiders | NA | 15,000 | 122,878 |
| Institutional | 77.48% | NA | NA |
| Change in Short Interest as of 3/15/2013 | -2.36% | ||
| Short Interest as % of Float as of 3/15/2013 | 4.99% | ||
| Number of Employees | 1,950 |
|---|---|
| Revenue per Employee | $706,911 |
| Income per Employee | $384,753 |
| Market Capitalization (thousands) | $18,072,300 |
| Enterprise Value (thousands) | $17,179,002 |
| Auditors Opinion | Unqualified |
Officers and Directors
P Roy Vagelos, Leonard S Schleifer, Murray A Goldberg, George Damis Yancopoulos, Neil Stahl, William G Roberts, Peter Powchik, William J Sasiela, Daniel P Van Plew, Robert J Terifay, Marc Tessier-Lavigne, Christine A Poon, Charles A Baker, Joseph L Goldstein, Michael S Brown, Eric M Shooter, Alfred G Gilman, George L Sing, Arthur Frederick Ryan, Douglas S McCorkle, Peter G Dworkin, Michael S Aberman, Joseph J LaRosa
